Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
04/27/2016 04/28/2016 04/29/2016 05/02/2016 05/03/2016 Date
5.66 5.74 5.54 5.55 5.58 Last
100 3200 2700 15475 2310 Volume
+2.91% +1.41% -3.48% +0.18% +0.54% Change
Financials ( CAD)
Sales 2016 35,9 M
EBIT 2016 -24,2 M
Net income 2016 -24,9 M
Debt 2016 -
Yield 2016 -
Sales 2017 42,2 M
EBIT 2017 -7,20 M
Net income 2017 -18,2 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 3,21x
Capi. / Sales 2017 2,73x
Capitalization 115 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company.It engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed products, BRINAVESS, approved in Europe and other... 
Sector
Pharmaceuticals
Calendar
06/21Shareholder meeting
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
04/28 CARDIOME PHARMA : to Present at the Bloom Burton & Co. 5th Annual Healthcare Inv..
03/31 CARDIOME PHARMA : Announces Publication of Independent Study Comparing BRINAVESS..
03/10 CARDIOME PHARMA : Reports Fourth Quarter and Full Year 2015 Financial Results
03/07 CARDIOME PHARMA : Announces Filing of Prospectus Supplements
03/04 CARDIOME PHARMA : To Hold Fourth Quarter And Full Year 2015 Financial Results Co..
02/19 CARDIOME PHARMA : announces filing of shelf prospectus and registration statemen..
02/10 CARDIOME PHARMA : To Present At The 5th Annual Leerink Partners Global Healthcar..
01/27 CARDIOME PHARMA : Announces Filing of Orphan Drug Application for Oral Vernakala..
More news
Sector news : Biopharmaceuticals
11:33a PFIZER : Drug Companies Pony Up in Illegal Marketing Cases, But Critics Wonder i..
10:25a C4X DISCOVERY : Moves Clive Fix From Chairman To Chief Executive
09:03a MERCK AT SID : Materials for the Displays of Today and Tomorrow
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/10 Cardiome Pharma's (CRME) CEO Bill Hunter on Q4 2015 Results - Earnings Call T..
03/10 Cardiome Pharma misses by $0.18, misses on revenue
03/09 Notable earnings before Thursday?s open
01/12 Cardiome inks $20M share purchase deal with Lincoln Park Capital
01/06 EMA to review Cardiome's Trevyent MAA under streamlined centralized procedure


Comments 
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions